Use of intravenous gammaglobulin as an immune replacement and an immune suppressant.

[1]  J. Winiarski,et al.  Immunological effects of intravenous gammaglobulin treatment in childhood idiopathic thrombocytopenic purpura. , 2009, Scandinavian journal of haematology.

[2]  R. Ljung,et al.  Platelet-associated IgG in childhood idiopathic thrombocytopenic purpura: measurements on intact and solubilized platelets and after gammaglobulin treatment. , 2009, Scandinavian journal of haematology.

[3]  W. Graninger,et al.  Treatment of severe chronic idiopathic thrombocytopenic purpura in adults with high-dose intravenous gammaglobulin. , 2009, Scandinavian journal of haematology.

[4]  A. Pesce,et al.  High dose intravenous gammaglobulin and platelet transfusions in leukaemic HLA-immunized patients. , 2009, Scandinavian journal of haematology.

[5]  G. Holm,et al.  High dose intravenous IgG reduces platelet associated immunoglobulins and complement in idiopathic thrombocytopenic purpura. , 2009, Scandinavian journal of haematology.

[6]  J. Bernard,et al.  Treatment of adult autoimmune thrombocytopenic purpura with high-dose intravenous plasmin-cleaved gammaglobulins. , 2009, Scandinavian journal of haematology.

[7]  R. Berkowitz,et al.  Antenatal treatment of neonatal alloimmune thrombocytopenia. , 1988, The New England journal of medicine.

[8]  A. Randomized.  Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial. , 1988 .

[9]  M. Eibl,et al.  Prevention of necrotizing enterocolitis in low-birth-weight infants by IgA-IgG feeding. , 1988, The New England journal of medicine.

[10]  J. Bussel,et al.  Isolated thrombocytopenia in patients infected with HIV: Treatment with intravenous gammaglobulin , 1988, American journal of hematology.

[11]  R. Gale,et al.  Clinical uses of intravenous immunoglobulins. , 1988, Seminars in hematology.

[12]  E. Besa.  Rapid transient reversal of anemia and long-term effects of maintenance intravenous immunoglobulin for autoimmune hemolytic anemia in patients with lymphoproliferative disorders. , 1988, The American journal of medicine.

[13]  F. Omeñaca,et al.  High-dose intravenous immunoglobulin as the sole prenatal treatment for severe Rh immunization. , 1988, The New England journal of medicine.

[14]  J. Bussel,et al.  Intravenous treatment with γ-globulin of autoimmune neutropenia of infancy , 1988 .

[15]  J. Kelton,et al.  Hypergammaglobulinemia can be associated with a positive direct antiglobulin test, a nonreactive eluate, and no evidence of hemolysis , 1988, Transfusion.

[16]  A. Lobuglio,et al.  Effect of commercial immunoglobulin G preparation on human monocyte Fc‐receptor dependent binding of antibody coated platelets , 1988, British journal of haematology.

[17]  R. Good,et al.  Non‐A Non‐B Hepatitis and the Safety of Intravenous Immune Globulin, pH 4.2: A Retrospective Survey: , 1988 .

[18]  J. Denburg,et al.  Hypogammaglobulinemia: therapeutic rationale. , 1987, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[19]  C. Suarez,et al.  High‐dose intravenous gammaglobulin (IVG) in neonatal immune thrombocytopenia , 1987, American journal of hematology.

[20]  R. Shadduck,et al.  High-dose intravenous gamma globulin improves responses to single-donor platelets in patients refractory to platelet transfusion. , 1987, Blood.

[21]  R. Hoffman,et al.  Treatment of antibody-mediated pure red-cell aplasia with high-dose intravenous gamma globulin. , 1987, The New England journal of medicine.

[22]  H. Ochs,et al.  Self-infusion of intravenous immunoglobulin by immunodeficient patients at home. , 1987, The Journal of infectious diseases.

[23]  H. Chapel,et al.  Mechanisms of infection in chronic lymphocytic leukemia. , 1987, Seminars in hematology.

[24]  G. Lucas,et al.  INTRAVENOUS IMMUNOGLOBULIN AND BLOOD-GROUP ANTIBODIES , 1987, The Lancet.

[25]  K. Kim,et al.  Intravenous immunoglobulins as therapeutic agents. , 1987, Annals of internal medicine.

[26]  C. Cordonnier,et al.  Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. , 1987, Blood.

[27]  S. Harada,et al.  Elimination of Viruses (Human Immunodeficiency, Hepatitis B, Vesicular Stomatitis and Sindbis Viruses) from an Intravenous Immunoglobulin Preparation , 1987, Vox sanguinis.

[28]  R. Furth,et al.  Opsonic and Physicochemical Characteristics of Intravenous Immunoglobulin Preparations , 1987, Vox sanguinis.

[29]  J. Lundblad,et al.  Characterisation of various intravenous immunoglobulin preparations. , 1987, The Journal of infection.

[30]  G. Massey,et al.  Intravenous immunoglobulin in treatment of neonatal isoimmune thrombocytopenia. , 1987, The Journal of pediatrics.

[31]  E. Fitzsimons,et al.  ALOPECIA AFTER IMMUNOGLOBULIN INFUSION , 1987, The Lancet.

[32]  P. Yap,et al.  DOSE OF INTRAVENOUS IgG IN PRIMARY HYPOGAMMAGLOBUTLINAEMIA , 1987, The Lancet.

[33]  M. Weyden,et al.  High dose intravenous gammaglobulin in Coombs positive hemolytic anemia. , 1987, Australian and New Zealand journal of medicine.

[34]  Henry Levison,et al.  HIGH-DOSE VERSUS LOW-DOSE INTRAVENOUS IMMUNOGLOBULIN IN HYPOGAMMAGLOBULINAEMIA AND CHRONIC LUNG DISEASE , 1987, The Lancet.

[35]  J. Moscow,et al.  Positive direct antiglobulin test results after intravenous immune globulin administration , 1987, Transfusion.

[36]  Edward J. Lee,et al.  Intravenous immune globulin for patients alloimmunized to random donor platelet transfusion , 1987, Transfusion.

[37]  W. Bleeker,et al.  An Animal Model for the Detection of Hypotensive Side Effects of Immunoglobulin Preparations , 1987, Vox sanguinis.

[38]  S. Kapur,et al.  Gammaglobulin for intravenous use induces an Fc gamma receptor-specific decrement in phagocytosis by blood monocytes. , 1987, Clinical immunology and immunopathology.

[39]  J. Bussel,et al.  Intravenous Treatment with Gammaglobulin in Adults with Immune Thrombocytopenic Purpura: Review of the Literature 1 , 1987, Vox sanguinis.

[40]  E. Wyshock,et al.  Improvement of neurologic function in chronic inflammatory demyelinating polyradiculoneuropathy following intravenous gamma-globulin infusion. , 1987, Archives of neurology.

[41]  K. Kim.  Efficacy of Human Immunoglobulin and Penicillin G in Treatment of Experimental Group B Streptococcal Infection , 1987, Pediatric Research.

[42]  B. Perret,et al.  Workshop on Immunoglobulin Therapy of Lymphoproliferative Syndromes, Mainly AIDS-Related Complex, and AIDS , 1987 .

[43]  A. Plebani,et al.  Intravenous gammaglobulin therapy for prophylaxis of infection in high-risk neonates. , 1987, The Journal of pediatrics.

[44]  R. Geha,et al.  Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin. , 1987, The Journal of clinical investigation.

[45]  P. Schur.  IgG subclasses--a review. , 1987, Annals of allergy.

[46]  A. Webster,et al.  IgG ANTIBODIES IN INTRAVENOUS GAMMAGLOBULINS , 1987, The Lancet.

[47]  R. Ash,et al.  Positive antiglobulin tests due to intravenous immunoglobulin in patients who received bone marrow transplant , 1987, Transfusion.

[48]  C. Cunningham-Rundles,et al.  Intravenous Treatment of Autoimmune Hemolytic Anemia with Very High Dose Gammaglobulin 1 , 1986, Vox sanguinis.

[49]  P. Yap,et al.  Increase of Serum Immunoglobulin Level into the Normal Range in Primary Hypogammaglobulinaemia by Dosage Individualisation of Intravenous Immunoglobulin , 1986, Vox sanguinis.

[50]  I. Warrier,et al.  Intravenous gammaglobulin (Gamimune) for treatment of chronic idiopathic thrombocytopenic purpura (ITP): A two‐year follow‐up , 1986 .

[51]  T. Yajima,et al.  Opsonic and Complement‐Dependent Bactericidal Activities of Various Immunoglobulin Preparations for Intravenous Use , 1986, Vox sanguinis.

[52]  P. Colonna,et al.  Anti-Fc-receptor therapy of refractory immune thrombocytopenic purpura. , 1986 .

[53]  M. H. Zaidi,et al.  Intravenous immunoglobulin for prevention of sepsis in preterm and low birth weight infants , 1986, Pediatric infectious disease.

[54]  S. Burdach,et al.  Treatment of acute idiopathic thrombocytopenic purpura of childhood with intravenous immunoglobulin G: comparative efficacy of 7S and 5S preparations. , 1986, The Journal of pediatrics.

[55]  B. Chong,et al.  An Unusual Case of Post‐Transfusion Purpura: Good Transient Response to High‐Dose Immunoglobulin , 1986, Vox sanguinis.

[56]  P. Feorino,et al.  Antibody against the human immunodeficiency virus in commercial intravenous gammaglobulin preparations. , 1986, Annals of internal medicine.

[57]  A. Johnson,et al.  Noncomparability among IgG products , 1986, Transfusion.

[58]  E. Copelan,et al.  Hemolysis following intravenous immune globulin therapy , 1986, Transfusion.

[59]  S. Pahwa.  Children with AIDS , 1986, Vox sanguinis.

[60]  D. Sidiropoulos,et al.  Experience with Intravenous Immunoglobulin Treatment in Neonates and Pregnant Women , 1986, Vox sanguinis.

[61]  G. V. von Muralt,et al.  Transplacental passage of intravenous immunoglobulin in the last trimester of pregnancy. , 1986, The Journal of pediatrics.

[62]  J. Bossell.  Safety of Therapeutic Immune Globulin Preparations with Respect to Transmission of Human T-Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus Infection , 1986, MMWR. Morbidity and mortality weekly report.

[63]  H. Cottier,et al.  Immunoglobulin in Chronic Inflammatory Diseases , 1986, Vox sanguinis.

[64]  J. Bussel.  Therapy in Cytopenia , 1986 .

[65]  E. Gelfand,et al.  Corticosteroids for prevention of adverse reactions to intravenous immune serum globulin infusions in hypogammaglobulinemic patients. , 1986, The American journal of medicine.

[66]  A. Morell.  Various Immunoglobulin Preparations for Intravenous Use , 1986, Vox sanguinis.

[67]  C. Cunningham-Rundles.  Treatment of AB Deficiencies , 1986, Vox sanguinis.

[68]  R. Schneerson,et al.  IgG Subclass Deficiencies , 1986, Vox sanguinis.

[69]  J. Schifferli,et al.  The role of complement and its receptor in the elimination of immune complexes. , 1986, The New England journal of medicine.

[70]  J. Newburger,et al.  The treatment of Kawasaki syndrome with intravenous gamma globulin. , 1986 .

[71]  Rauch Ae,et al.  Thrombocytopenic purpura and infectious mononucleosis. A possible role for high dose intravenous immunoglobulin. , 1986 .

[72]  Tohru Suzuki,et al.  A New Intact Immunoglobulin for Intravenous Use Stabilized by Chemically Modified Gelatin Derivatives , 1986, Vox sanguinis.

[73]  A. Grigg,et al.  FATAL THROMBOTIC EVENTS DURING TREATMENT OF AUTOIMMUNE THROMBOCYTOPENIA WITH INTRAVENOUS IMMUNOGLOBULIN IN ELDERLY PATIENTS , 1986, The Lancet.

[74]  M. Leahy.  SUBCUTANEOUS IMMUNOGLOBULIN HOME TREATMENT IN HYPOGAMMAGLOBULINAEMIA , 1986, The Lancet.

[75]  T. Baglin,et al.  ANTI-Rh(D) IMMUNOGLOBULIN FOR IMMUNE THROMBOCYTOPENIC PURPURA , 1986, The Lancet.

[76]  G. Pier,et al.  Active and passive immunization strategies for Pseudomonas aeruginosa pneumonia. , 1986, Reviews of infectious diseases.

[77]  A. Salama,et al.  Effect of IgG anti‐Rho(D) in adult patients with chronic autoimmune thrombocytopenia , 1986, American journal of hematology.

[78]  H. Hill,et al.  Protective and opsonic activities of a native, pH 4.25 intravenous immunoglobulin G preparation against common bacterial pathogens. , 1986, Reviews of infectious diseases.

[79]  T. Emerson,et al.  Use of a new, low-pH immunoglobulin G preparation during episodes of bacteremia in the rat. , 1986, Reviews of Infectious Diseases.

[80]  A. Hässig.  Intravenous Immunoglobulins: Pharmacological Aspects and Therapeutic Use , 1986, Vox sanguinis.

[81]  M. Collins,et al.  Immunoglobulin G: potentiation of tobramycin and azlocillin in the treatment of Pseudomonas aeruginosa sepsis in neutropenic mice and neutralization of exotoxin A in vivo. , 1986, Reviews of infectious diseases.

[82]  J. Lundblad,et al.  Comparative studies of impurities in intravenous immunoglobulin preparations. , 1986, Reviews of infectious diseases.

[83]  D. Heiner.  IgG subclass composition of intravenous immunoglobulin preparations: clinical relevance. , 1986, Reviews of infectious diseases.

[84]  D. Grob,et al.  High-dose intravenous immunoglobulin in the management of myasthenia gravis. , 1986, Archives of internal medicine.

[85]  B. Pirofsky.  Safety and toxicity of a new serum immunoglobulin G intravenous preparation, IGIV pH 4.25. , 1986, Reviews of infectious diseases.

[86]  R. Schiff.  Half-life and clearance of pH 6.8 and pH 4.25 immunoglobulin G intravenous preparations in patients with primary disorders of humoral immunity. , 1986, Reviews of infectious diseases.

[87]  H. Hill,et al.  Effect of intravenous immunoglobulin G on neutrophil kinetics during experimental group B streptococcal infection in neonatal rats. , 1986, Reviews of infectious diseases.

[88]  J. Mccue,et al.  Three generations of immunoglobulin G preparations for clinical use. , 1986, Reviews of infectious diseases.

[89]  Y. Laurian,et al.  Immune thrombocytopenia gammaglobulin, and positivity to the human T-lymphotropic virus type III. , 1986, Annals of internal medicine.

[90]  W. Stohl.  Cellular mechanisms in the in vitro inhibition of pokeweed mitogen-induced B cell differentiation by immunoglobulin for intravenous use. , 1986, Journal of immunology.

[91]  R S Lane,et al.  Important Parameters in Plasma Fractionation , 1986, Vox sanguinis.

[92]  R. Aster,et al.  Urgent treatment of idiopathic thrombocytopenic purpura with single-dose gammaglobulin infusion followed by platelet transfusion. , 1986, Annals of internal medicine.

[93]  J. Hall,et al.  Comparison of intravenous gamma globulin and a monoclonal anti-Fc receptor antibody as inhibitors of immune clearance in vivo in mice. , 1986, The Journal of clinical investigation.

[94]  A. Wittek,et al.  AIDS, blood transfusions, and directed donations. , 1986 .

[95]  R. Kimberly,et al.  Treatment of refractory immune thrombocytopenic purpura with an anti-Fcγ-receptor antibody , 1986 .

[96]  O. Weiland,et al.  NON-A, NON-B HEPATITIS AFTER INTRAVENOUS GAMMAGLOBULIN , 1986, The Lancet.

[97]  N. Flournoy,et al.  Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. , 1986, The New England journal of medicine.

[98]  G. Asherson,et al.  ISOLATION OF RETROVIRUSES FROM TWO PATIENTS WITH "COMMON VARIABLE" HYPOGAMMAGLOBULINAEMIA , 1986, The Lancet.

[99]  J. Epstein,et al.  Inactivation and partition of human T‐cell lymphotrophic virus, type III, during ethanol fractionation of plasma , 1986, Transfusion.

[100]  L. Huebsch,et al.  Treatment of gold-induced thrombocytopenia by high-dose intravenous gamma globulin. , 1986, Arthritis and rheumatism.

[101]  DiTuro Wj,et al.  Intravenous gammaglobulin treatment of profound herpes varicella zoster associated thrombocytopenia. , 1986 .

[102]  R. H. Painter,et al.  An examination of the structural and biological properties of three intravenous immunoglobulin preparations. , 1986, Molecular immunology.

[103]  A. Burks,et al.  Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA. , 1986, The New England journal of medicine.

[104]  J. Barquinero,et al.  Serum thrombocytopenia and high-dose immunoglobulin treatment. , 1986, Annals of internal medicine.

[105]  K. Raška,et al.  HTLV-III ANTIBODY IN COMMERCIAL IMMUNOGLOBULIN , 1986, The Lancet.

[106]  H. Niessner,et al.  Immune thrombocytopenia in severe hemophilia A treated with high‐dose intravenous immunoglobulin , 1986, Transfusion.

[107]  F. Dammacco,et al.  Treatment of adult patients with idiopathic thrombocytopenic purpura with intravenous immunoglobulin: effects on circulating T cell subsets and PWM‐induced antibody synthesis in vitro , 1986, British journal of haematology.

[108]  A. Fasth.  Immunoglobulin for neonatal agranulocytosis. , 1986, Archives of disease in childhood.

[109]  E. Montserrat,et al.  Hodgkin's disease in external mammary lymph nodes. , 1985, Annals of internal medicine.

[110]  J. Roujeau,et al.  Bullous pemphigoid and intravenous gammaglobulin. , 1985, Annals of internal medicine.

[111]  A. Nakamura,et al.  High-dose intravenous intact IgG infusion in refractory autoimmune hemolytic anemia (Evans syndrome). , 1985, The Journal of pediatrics.

[112]  J. Speelman,et al.  Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy , 1985, Journal of the Neurological Sciences.

[113]  B. Bake,et al.  Impaired lung function in patients with IgA deficiency and low levels of IgG2 or IgG3. , 1985, The New England journal of medicine.

[114]  R. Schiff.  Individualizing the Dose of Intravenous Immune Serum Globulin for Therapy of Patients with Primary Humoral Immunodeficiency , 1985, Vox sanguinis.

[115]  J. Bussel.  Intravenous Immune Serum Globulin in Immune Thrombocytopenia: Clinical Results and Biochemical Evaluation , 1985, Vox sanguinis.

[116]  C. Cunningham-Rundles.  Intravenous Immune Serum Globulin in Immunodeficiency , 1985, Vox sanguinis.

[117]  R. Sprenger,et al.  High‐dose intravenous immunoglobulin for post‐transfusion purpura , 1985, British journal of haematology.

[118]  J. Gauldie,et al.  The concentration of IgG in the serum is a major determinant of Fc-dependent reticuloendothelial function. , 1985, Blood.

[119]  G. Gaedicke,et al.  INTRAVENOUS IMMUNOGLOBULIN VERSUS ORAL CORTICOSTEROIDS IN ACUTE IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDHOOD , 1985, The Lancet.

[120]  C. Engelfriet,et al.  Intravenous Gammaglobulin Therapy in Idiopathic Thrombocytopenic Purpura , 1985 .

[121]  G. Mufti,et al.  Successful Treatment of Post‐Transfusion Purpura with High Dose Immunoglobulins after Lack of Response to Plasma Exchange , 1985, Vox sanguinis.

[122]  H. Levison,et al.  Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease. , 1985, The American journal of medicine.

[123]  P. Griffiths,et al.  SPECIFIC HYPERIMMUNE GLOBULIN FOR CYTOMEGALOVIRUS PNEUMONITIS , 1985, The Lancet.

[124]  G. Gaedicke,et al.  Gamma‐globulin Therapy in 6 Newly Diagnosed Diabetic Children , 1985, Acta paediatrica Scandinavica.

[125]  J. Kelton.  Advances in the diagnosis and management of ITP. , 1985, Hospital practice.

[126]  B. Combe,et al.  Human placenta-eluted gammaglobulins in immunomodulating treatment of rheumatoid arthritis. , 1985, The American journal of medicine.

[127]  G. Buchanan.  Childhood acute idiopathic thrombocytopenic purpura: how many tests and how much treatment required? , 1985, The Journal of pediatrics.

[128]  E. Macintyre,et al.  SUCCESSFUL RESPONSE TO INTRAVENOUS IMMUNOGLOBULIN IN AUTOIMMUNE HAEMOLYTIC ANAEMIA , 1985, British journal of haematology.

[129]  J. Delfraissy,et al.  Suppressor cell function after intravenous gammaglobulin treatment in adult chronic idiopathic thrombocytopenic purpura , 1985, British journal of haematology.

[130]  J. Bussel,et al.  Treatment of acute idiopathic thrombocytopenia of childhood with intravenous infusions of gammaglobulin. , 1985, The Journal of pediatrics.

[131]  E. Besa,et al.  High‐dose intravenous igg in the management of pregnancy in women with idiopathic thrombocytopenic purpura , 1985, American journal of hematology.

[132]  P. Yap,et al.  NON-A, NON-B HEPATITIS AND INTRAVENOUS IMMUNOGLOBULIN , 1985, The Lancet.

[133]  D. Burton.  Immunoglobulin G: functional sites. , 1985, Molecular immunology.

[134]  R. Ljung,et al.  HIGH-DOSE INTRAVENOUS GAMMABLOBULIN: A CAUTIONARY NOTE , 1985, The Lancet.

[135]  H. Kingdon,et al.  NON-A, NON-B HEPATITIS AND INTRAVENOUS IMMUNOGLOBULIN , 1985, The Lancet.

[136]  B. Kommerell,et al.  INTRAVENOUS IgG FOR PATIENTS WITH SPONTANEOUS INHIBITOR TO FACTOR VIII , 1985, The Lancet.

[137]  S. Sacchi,et al.  LOW‐DOSE INTRAVENOUS PEPSIN‐TREATED GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS , 1984, British journal of haematology.

[138]  J. Kurtzberg,et al.  High-dose intravenous immunoglobulin for severe platelet alloimmunization. , 1984, Pediatrics.

[139]  C. Milstein,et al.  Somatic mutation and the maturation of immune response to 2-phenyl oxazolone , 1984, Nature.

[140]  H. Thomas,et al.  NON-A, NON-B HEPATITIS OCCURRING IN AGAMMAGLOBULINAEMIC PATIENTS AFTER INTRAVENOUS IMMUNOGLOBULIN , 1984, The Lancet.

[141]  T. Barbui,et al.  PURE WHITE CELL APLASIA TREATED BY HIGH DOSE INTRAVENOUS IMMUNOGLOBULIN , 1984, British journal of haematology.

[142]  M. Kazatchkine,et al.  ANTI-IDIOTYPIC SUPPRESSION OF AUTOANTIBODIES TO FACTOR VIII (ANTIHAEMOPHILIC FACTOR) BY HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN , 1984, The Lancet.

[143]  V. Cosi,et al.  HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR MYASTHENIA GRAVIS , 1984, The Lancet.

[144]  R. Miniero,et al.  Fc-depleted vs intact intravenous immunoglobulin in chronic ITP. , 1984, The Journal of pediatrics.

[145]  C. Cunningham-Rundles,et al.  Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease. , 1984, Annals of internal medicine.

[146]  C. Schiffer,et al.  High-dose intravenous gammaglobulin in alloimmunized platelet transfusion recipients , 1984 .

[147]  A. Cooke,et al.  AUTOIMMUNITY AND IDIOTYPES , 1984, The Lancet.

[148]  S. Karpatkin,et al.  On the mechanism of thrombocytopenic purpura in sexually active homosexual men. , 1984, The New England journal of medicine.

[149]  W. Buchanan,et al.  The relationship among platelet-associated IgG, platelet lifespan, and reticuloendothelial cell function , 1984 .

[150]  J. Akatsuka,et al.  A Cooperative Clinical Trial of High-Dose Immunoglobulin Therapy in 177 Cases of Idiopathic Thrombocytopenic Purpura , 1984, Thrombosis and Haemostasis.

[151]  J. Sadoff,et al.  INTRAVENOUS IMMUNE GLOBULIN: A CAUTIONARY NOTE , 1984, The Lancet.

[152]  R. van Furth,et al.  Correlation between opsonic activity for various microorganisms and composition of gammaglobulin preparations for intravenous use. , 1984, The Journal of infectious diseases.

[153]  R. Buckley,et al.  Use of a new chemically modified intravenous IgG preparation in severe primary humoral immunodeficiency: clinical efficacy and attempts to individualize dosage. , 1984, Clinical immunology and immunopathology.

[154]  Y. Ahn,et al.  High-dose intravenous gamma globulin to suppress alloimmune destruction of donor platelets. , 1984, The American journal of medicine.

[155]  M. Collins,et al.  Comparative anti-Pseudomonas aeruginosa activity of chemically modified and native immunoglobulin G (human), and potentiation of antibiotic protection against Pseudomonas aeruginosa and group B Streptococcus in vivo. , 1984, The American journal of medicine.

[156]  B. Pirofsky.  Intravenous immune globulin therapy in hypogammaglobulinemia. A review. , 1984, The American journal of medicine.

[157]  J. Lewis,et al.  Intravenous gamma globulin in the treatment of chronic idiopathic thrombocytopenic purpura in adults. , 1984, The American journal of medicine.

[158]  A. Munster.  Immunologic response of trauma and burns. An overview. , 1984, The American journal of medicine.

[159]  V. Wahn,et al.  Adverse reactions in selected patients following intravenous infusions of gamma globulin. , 1984, The American journal of medicine.

[160]  H. Ochs,et al.  Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases. , 1984, The American journal of medicine.

[161]  J. Graham-Pole,et al.  Improved response of patients refractory to random-donor platelet transfusions by intravenous gamma globulin. , 1984, The American journal of medicine.

[162]  B. Curfman,et al.  Intravenous immunoglobulin in neonatal group B streptococcal disease. Pharmacokinetic and safety studies in monkeys and humans. , 1984, The American journal of medicine.

[163]  A. Dalhoff.  Synergy between acylureidopenicillins and immunoglobulin G in experimental animals. , 1984, The American journal of medicine.

[164]  W. Rosse,et al.  Intravenous immunoglobulin administration in the treatment of severe chronic immune thrombocytopenic purpura. , 1984, The American journal of medicine.

[165]  R. Sorensen,et al.  Efficacy and safety of high-dose intravenous immune globulin therapy for antibody deficiency syndromes. , 1984, The American journal of medicine.

[166]  J. Naglich,et al.  Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa. Treatment with intravenous immune globulin. , 1984, The American journal of medicine.

[167]  M. Wick,et al.  HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR MYASTHENIA GRAVIS , 1984, The Lancet.

[168]  R. Kimberly,et al.  Modulation of mononuclear phagocyte function by intravenous gamma-globulin. , 1984, Journal of immunology.

[169]  Newland Ac,et al.  Intravenous IgG for autoimmune thrombocytopenia in pregnancy. , 1984 .

[170]  J. Bussel,et al.  THE USE AND MECHANISM OF ACTION OF INTRAVENOUS IMMUNOGLOBULIN IN THE TREATMENT OF IMMUNE HAEMATOLOGIC DISEASE , 1984, British journal of haematology.

[171]  Lennart Hammarstrom,et al.  Anti‐IgA in Selective IgA Deficiency , 1983, Scandinavian journal of immunology.

[172]  D. Sidiropoulos,et al.  [Replacement therapy with immunoglobulins in neonatology]. , 1983, Presse medicale.

[173]  D. Segal,et al.  The role of non-immune IgG in controlling IgG-mediated effector functions. , 1983, Molecular immunology.

[174]  R. Miniero,et al.  Chronic idiopathic thrombocytopenia treated with immunoglobulin. , 1983, Archives of disease in childhood.

[175]  R. Lane,et al.  NON-A, NON-B HEPATITIS FROM INTRAVENOUS IMMUNOGLOBULIN , 1983, The Lancet.

[176]  A. Ugazio,et al.  High-dose intravenous gammaglobulin therapy for passive immune thrombocytopenia in the neonate. , 1983, The Journal of pediatrics.

[177]  J. Bussel,et al.  Intravenous use of gammaglobulin in the treatment of chronic immune thrombocytopenic purpura as a means to defer splenectomy. , 1983, The Journal of pediatrics.

[178]  J. Kelton,et al.  The amount of platelet-bound albumin parallels the amount of IgG on washed platelets from patients with immune thrombocytopenia , 1983 .

[179]  W. Vainchenker,et al.  TREATMENT OF PURE RED CELL APLASIA BY HIGH DOSE INTRAVENOUS IMMUNOGLOBULINS , 1983, British journal of haematology.

[180]  A. Marmont,et al.  INTRAVENOUS IMMUNOGLOBULIN IN IMMUNE THROMBOCYTOPENIA , 1983, The Lancet.

[181]  Y. Kanakura,et al.  Alteration of T cell subsets and immunoglobulin synthesis in vitro during high dose gamma-globulin therapy in patients with idiopathic thrombocytopenic purpura. , 1983, Clinical and experimental immunology.

[182]  C. Cunningham-Rundles,et al.  Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura , 1983 .

[183]  J. Bussel,et al.  Reversal of neutropenia with intravenous gammaglobulin in autoimmune neutropenia of infancy. , 1983, Blood.

[184]  F. Seiler,et al.  S‐Sulfonation: a Reversible Chemical Modification of Human Immunoglobulins Permitting Intravenous Application , 1983, Vox sanguinis.

[185]  H. Schorlemmer,et al.  S‐Sulfonation: a Reversible Chemical Modification of Human Immunoglobulins Permitting Intravenous Application , 1983, Vox sanguinis.

[186]  Kimio Ogawa,et al.  HIGH DOSE GAMMAGLOBULIN FOR INTRACTABLE CHILDHOOD EPILEPSY , 1983, The Lancet.

[187]  A. Salama,et al.  EFFECT OF INTRAVENOUS IMMUNOGLOBULIN IN IMMUNE THROMBOCYTOPENIA Competitive Inhibition of Reticuloendothelial System Function by Sequestration of Autologous Red Blood Cells? , 1983, The Lancet.

[188]  D. Snydman,et al.  Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. , 1983, Annals of internal medicine.

[189]  W. Noyes,et al.  High-dose intravenous immunoglobulin therapy in patients with immune thrombocytopenic purpura. , 1983, JAMA.

[190]  D. Mcclelland,et al.  HYPERIMMUNE IMMUNOGLOBULIN FOR CYTOMEGALOVIRUS INFECTIONS , 1983, The Lancet.

[191]  R. Mcintosh,et al.  HUMAN IMMUNOGLOBULIN FOR CLINICAL USE , 1983, The Lancet.

[192]  N. Grunnet,et al.  High-dose intravenous immunoglobulin for post-transfusion purpura. , 1983, Scandinavian journal of haematology.

[193]  U. Nydegger,et al.  Monomeric IgG preparations for intravenous use inhibit platelet stimulation by polymeric IgG , 1983, British journal of haematology.

[194]  D. Birmingham,et al.  Primate erythrocyte-immune complex-clearing mechanism. , 1983, The Journal of clinical investigation.

[195]  A. Newland,et al.  HIGH-DOSE INTRAVENOUS IgG IN ADULTS WITH AUTOIMMUNE THROMBOCYTOPENIA , 1983, The Lancet.

[196]  W. Rosse,et al.  Characterization of the IgG-Fc receptor on human platelets , 1982 .

[197]  G. Mueller‐Eckhardt,et al.  Platelet associated IgG, platelet survival, and platelet sequestration in thrombocytopenic states , 1982, British journal of haematology.

[198]  P. Bierling,et al.  INCREASE-PLATELET-ASSOCIATED IgG IN PATIENT ON HIGH-DOSE GAMMAGLOBULIN FOR AUTOIMMUNE THROMBOCYTOPENIC PURPURA , 1982, The Lancet.

[199]  D. Rose,et al.  The generation of antibody diversity , 1982, American journal of hematology.

[200]  C. Cunningham-Rundles,et al.  Antinuclear antibody staining only centrioles in a patient with scleroderma. , 1982 .

[201]  B. Schmidt,et al.  INCREASED PLATELET-ASSOCIATED IgG IN CHILD ON HIGH-DOSE GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA , 1982, The Lancet.

[202]  T. Merigan,et al.  Cytomegalovirus immune plasma in bone marrow transplant recipients. , 1982, Annals of internal medicine.

[203]  J. Melby,et al.  ENALAPRIL (MK-421) AND THE WHITE CELL COUNT AND HAEMATOCRIT , 1982, The Lancet.

[204]  J. Fehr,et al.  Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. , 1982, The New England journal of medicine.

[205]  P Leder,et al.  The genetics of antibody diversity. , 1982, Scientific American.

[206]  R. Good.  Introductory comments , 1982, Journal of Clinical Immunology.

[207]  J. Kelton,et al.  Autoimmune Platelet Destruction: Idiopathic Thrombocytopenic Purpura , 1982, Seminars in thrombosis and hemostasis.

[208]  W. Kuis,et al.  Home treatment in patients with antibody deficiency by slow subcutaneous infusion of gammaglobulin. , 1982, Lancet.

[209]  J. Morgenthaler,et al.  Characterization of various immunoglobulin preparations for intravenous application. I. Protein composition and antibody content. , 1982, Vox sanguinis.

[210]  G. V. von Muralt,et al.  [Immunoglobulin substitution in the treatment of neonatal septicemia]. , 1981, Schweizerische medizinische Wochenschrift.

[211]  S. Karpatkin,et al.  Platelet Counts in Infants of Women with Autoimmune Thrombocytopenia , 1981 .

[212]  D. Segal,et al.  C1q binding to antibody-coated cells: predictions from a simple multivalent binding model. , 1981, Molecular immunology.

[213]  U. Budde,et al.  HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA , 1981, The Lancet.

[214]  R. Geha.  Regulation of the immune response by idiotypic-antiidiotypic interactions. , 1981, The New England journal of medicine.

[215]  L. Hanson,et al.  IgG subclasses in selective IgA deficiency: importance of IgG2-IgA deficiency. , 1981, The New England journal of medicine.

[216]  A. Hirt,et al.  HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD , 1981, The Lancet.

[217]  R. Mcmillan.  Chronic idiopathic thrombocytopenic purpura. , 1981, The New England journal of medicine.

[218]  C. Abildgaard,et al.  Intracranial hemorrhage in children with idiopathic thrombocytopenic purpura. , 1981, Pediatrics.

[219]  R. Mcmillan,et al.  Fixation of C3 to Platelets in Vitro by Antiplatelet Antibody from Patients with Immune Thrombocytopenic Purpura , 1981, British journal of haematology.

[220]  R. J. Jones,et al.  CONTROLLED TRIAL OF PSEUDOMONAS IMMUNOGLOBULIN AND VACCINE IN BURN PATIENTS , 1980, The Lancet.

[221]  P. Tani,et al.  The demonstration of antibody binding to platelet-associated antigens in patients with immune thrombocytopenic purpura. , 1980, Blood.

[222]  R. Buckley,et al.  SAFETY AND PATIENT ACCEPTABILITY OF INTRAVENOUS IMMUNE GLOBULIN IN 10% MALTOSE , 1980, The Lancet.

[223]  S. Karpatkin.  Autoimmune thrombocytopenic purpura. , 1980, The American journal of the medical sciences.

[224]  J. Finlayson,et al.  Contact-activated factors: contaminants of immunoglobulins preparations with coagulant and vasoactive properties. , 1980, The Journal of laboratory and clinical medicine.

[225]  J. Lundblad,et al.  Preparation of a Stable Intravenous Gamma‐Globulin: Process Design and Scale‐Up , 1980, Vox sanguinis.

[226]  A. Fauci,et al.  Immunoglobulin replacement therapy by slow subcutaneous infusion. , 1980, Annals of internal medicine.

[227]  N. Gengozian,et al.  IgG+ platelets in the marmoset: their induction, maintenance, and survival , 1980 .

[228]  J. Engel,et al.  Dimeric, trimeric and tetrameric complexes of immunoglobulin G fix complement. , 1980, The Biochemical journal.

[229]  L. Kernoff,et al.  Influence of the amount of platelet-bound IgG on platelet survival and site of sequestration in autoimmune thrombocytopenia. , 1980, Blood.

[230]  Opie Lh.  Drugs and the heart. V. Digitalis and sympathomimetic stimulants. , 1980 .

[231]  J. Tschopp,et al.  Antigen‐independent activation of the first component of complement C1 by chemically crosslinked rabbit IgG‐oligomers , 1980, FEBS letters.

[232]  M. R. Purnell,et al.  Novel inhibitors of poly(ADP-ribose) synthetase. , 1980, The Biochemical journal.

[233]  E. Tabor,et al.  TRANSMISSION OF HEPATITIS B BY IMMUNE SERUM GLOBULIN , 1979, The Lancet.

[234]  N. Mcwilliams,et al.  Acute idiopathic thrombocytopenic purpura in children , 1979, American journal of hematology.

[235]  A. Zuckerman,et al.  EPIDEMIC HEPATITIS B CAUSED BY COMMERCIAL HUMAN IMMUNOGLOBULIN , 1979, The Lancet.

[236]  B. Golding,et al.  Intravenous immunoglobulin therapy for antibody deficiency. , 1979, Clinical and experimental immunology.

[237]  J. Najarian,et al.  Treatment of life-threatening infections in renal transplant recipients with high-dose intravenous human IgG. , 1979, Transplantation proceedings.

[238]  B. Stockinger,et al.  Fc receptor dependency of antibody mediated feedback regulation: on the mechanism of inhibition. , 1978, Cellular immunology.

[239]  J. White,et al.  SERUM-α-HYDROXYBUTYRATE LEVELS IN SICKLE-CELL DISEASE AND SICKLE-CELL CRISIS , 1978, The Lancet.

[240]  M. Schanfield,et al.  Anaphylactic reactions to plasma infusions in patients with hypogammaglobulinemia and anti-IgA antibodies. , 1977, Clinical immunology and immunopathology.

[241]  Y. Masuho,et al.  Development of an Intravenous γ‐Globulin with Fc Activities , 1977 .

[242]  S. De Flora,et al.  Hepatitis B in subjects treated with a drug containing immunoglobulins. , 1977, The Journal of infectious diseases.

[243]  B. Trappler,et al.  ŒSTROGENS IN ISCHÆMIC HEART-DISEASE , 1976, The Lancet.

[244]  M. Imai,et al.  DECREASING FREQUENCY OF e ANTIGEN WITH AGE IN SERUM OF SYMPTOM-FREE CARRIERS OF HEPATITIS B ANTIGEN , 1976, The Lancet.

[245]  Miles Dp,et al.  Letter: Breast feeding. , 1976 .

[246]  G. Morley.  ASBESTOS IN THE AIR , 1976, The Lancet.

[247]  Stewart Gt,et al.  WHOOPING-COUGH VACCINATION , 1976, The Lancet.

[248]  Shozo Nakamura,et al.  ACUTE HEPATITIS B AFTER ADMINISTRATION OF GAMMAGLOBULIN , 1976, The Lancet.

[249]  Open Ba,et al.  George Frederick Rowbotham. , 1975 .

[250]  F. K Wurapa,et al.  SMALLPOX VACCINATION IN INFANCY , 1975, The Lancet.

[251]  G. Miller,et al.  A new complement function: solubilization of antigen-antibody aggregates. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[252]  T. Starzl,et al.  PORTACAVAL SHUNT IN HYPERLIPIDÆMIA , 1974 .

[253]  J. Bonnar,et al.  Letter: Prostaglandins and pre-eclampsia. , 1974, Lancet.

[254]  Z. Vlahcevic,et al.  Letter: Adverse reaction to gamma globulin due to hypersensitivity to thimerosal. , 1974, The New England journal of medicine.

[255]  E. Coles,et al.  ŒSTROGEN/CREATININE RATIOS , 1974 .

[256]  N. Ehlers,et al.  Letter: HL-A27 in acute and chronic uveitis. , 1974, Lancet.

[257]  A. Zuckerman,et al.  Infusion of hepatitis-B antibody in antigen-positive active chronic hepatitis. , 1973, Lancet.

[258]  P. R. Betts,et al.  Juvenile nephrono phthisis , 1973 .

[259]  M. Davis,et al.  Letter: Mentally subnormal children and their families. , 1973, Lancet.

[260]  L. Vallet,et al.  The Characterisation and Stability during Storage of Human Immunoglobulin Prepared for Clinical Use , 1973, Vox sanguinis.

[261]  J. V. Tongeren,et al.  The Significance of the Presence of Anti‐IgA Antibodies in Individuals with an IgA Deficiency* , 1973, European journal of clinical investigation.

[262]  A. Polson,et al.  Fractionation of Plasma with Polyethylene Glycol , 1972, Vox sanguinis.

[263]  H. Evans,et al.  Serum immunoglobulin levels in premature and full-term infants. , 1971, American journal of clinical pathology.

[264]  J. Parsons,et al.  Carpometacarpal osteoarthritis of the thumb. , 1970, Lancet.

[265]  T. Waldmann,et al.  Metabolic properties of IgG subclasses in man. , 1970, The Journal of clinical investigation.

[266]  R. D. Wochner.  Hypercatabolism of normal IgG; an unexplained immunoglobulin abnormality in the connective tissue diseases. , 1970, The Journal of clinical investigation.

[267]  G. Gleich,et al.  Anaphylactic transfusion reactions associated with anti-IgA antibody. , 1969, The New England journal of medicine.

[268]  H. Perkins,et al.  Anaphylactoid transfusion reactions associated with anti-IgA. , 1968, Lancet.

[269]  C. Janeway,et al.  Metabolism of gamma globulin fragments in normal and agammaglobulinemic persons. , 1968, The New England journal of medicine.

[270]  S. Salmon,et al.  Role of gamma globulin for immunoprophylaxis in multiple myeloma. , 1967, The New England journal of medicine.

[271]  S. I. Choi,et al.  Idiopathic thrombocytopenic purpura in childhood. , 1967, Canadian Medical Association journal.

[272]  Sgouris Jt.  The preparation of plasmin treated immune serum globulin for intravenous use. , 1967 .

[273]  M. Steinbuch,et al.  The preparation of gamma-globulin for intravenous use in Paris. , 1967, Vox sanguinis.

[274]  H. Koblet,et al.  Turnover of standard-gammaglobulin, pH-4-gammaglobulin and pepsin desaggregated gammaglobulin and clinical implications. , 1967, Vox sanguinis.

[275]  F. Dixon,et al.  THE EFFECT OF PASSIVELY ADMINISTERED ANTIBODY ON ANTIBODY SYNTHESIS , 1967, The Journal of experimental medicine.

[276]  C. Janeway,et al.  The gamma globulins. IV. Therapeutic uses of gamma globulin. , 1966, The New England journal of medicine.

[277]  W. W. Buchanan,et al.  LYSOSOMES IN DIVIDING CELLS. , 1965, Lancet.

[278]  Hicks He.  A PROPHYLACTIC AGAINST RESPIRATORY INFECTIONS. , 1965 .

[279]  M. Marshall.  STERILISATION BY STEAM UNDER INCREASED PRESSURE; A THIRD COMMUNICATION TO THE MEDICAL RESEARCH COUNCIL BY THE WORKING PARTY ON PRESSURE-STEAM STERILISERS. , 1964, Lancet.

[280]  Hugh Ae,et al.  BROAD-SPECTRUM REDEFINED. , 1963 .

[281]  H. Schultze,et al.  Über neue Möglichkeiten intravenöser Gammaglobulin-Applikation , 1962 .

[282]  P. Kistler,et al.  Large Scale Production of Human Plasma Fractions , 1962 .

[283]  H. Isliker,et al.  Intravenous Administration of Human γ‐Globulin * , 1962 .

[284]  D. E. Rogers,et al.  STUDIES ON BACTERIEMIA , 1961, The Journal of experimental medicine.

[285]  B. Bouroncle,et al.  IDIOPATHIC AND SECONDARY THROMBOCYTOPENIC PURPURA: CLINICAL STUDY AND EVALUATION OF 381 CASES OVER A PERIOD OF 28 YEARS , 1960 .

[286]  Varco Rl,et al.  A clinical and experimental study of agammaglobulinemia. , 1955 .

[287]  W. Dameshek,et al.  Idiopathic thrombocytopenia; review of eighty-nine cases with particular reference to the differentiation and treatment of acute (self-limited and chronic types). , 1951, A.M.A. archives of internal medicine.

[288]  W. Harrington,et al.  Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. , 1951, The Journal of laboratory and clinical medicine.

[289]  J. Oncley,et al.  The separation of the antibodies, isoagglutinins, prothrombin, plasminogen and beta1-lipoprotein into subfractions of human plasma. , 1949, Journal of the American Chemical Society.

[290]  Strong Le,et al.  Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. , 1946 .

[291]  E. Kabat,et al.  AN ELECTROPHORETIC STUDY OF IMMUNE SERA AND PURIFIED ANTIBODY PREPARATIONS , 1939, The Journal of experimental medicine.

[292]  C. Cunningham-Rundles,et al.  Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency. , 1988, The American journal of medicine.

[293]  J. Finlayson,et al.  Immunoglobulin G dimer: an idiotype-anti-idiotype complex. , 1988, Molecular immunology.

[294]  R. Buckley,et al.  Successful treatment of autoimmune hemolytic anemia in common variable immunodeficiency with high-dose intravenous gamma globulin. , 1987, The American journal of medicine.

[295]  R. Gale,et al.  Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. , 1987, Annals of internal medicine.

[296]  M. Glauser,et al.  Controversies in the use of passive immunotherapy for bacterial infections in the critically ill patient. , 1987, Reviews of infectious diseases.

[297]  E. Morgan,et al.  Biological activities residing in the Fc region of immunoglobulin. , 1987, Advances in immunology.

[298]  L. M. Hang,et al.  Immunodeficiency associated with motor neuron disease treated with intravenous immunoglobulin. , 1986, Clinical therapeutics.

[299]  J. Waner,et al.  Effect of intravenous immune globulin on natural killer cell activity: possible association with autoimmune neutropenia and idiopathic thrombocytopenia. , 1986, The Journal of pediatrics.

[300]  R. Lin,et al.  In vivo reduction of circulating C1q binding immune complexes by intravenous gammaglobulin administration. , 1986, International archives of allergy and applied immunology.

[301]  M. Dechavanne,et al.  Intravenous plasmin-treated gammaglobulin therapy in idiopathic thrombocytopenic purpura. Results in 40 patients. , 1985, Nouvelle revue francaise d'hematologie.

[302]  S. Tarui,et al.  High-dose gammaglobulin therapy for idiopathic thrombocytopenic purpura in adults. , 1983, Acta haematologica.

[303]  G. Chirico.  High-dose intravenous gammaglobulin therapy for passive immune thrombocytopenia , 1983 .

[304]  R. Kurlander,et al.  The binding of human immunoglobulin G1 monomer and small, covalently cross-linked polymers of immunoglobulin G1 to human peripheral blood monocytes and polymorphonuclear leukocytes. , 1982, The Journal of clinical investigation.

[305]  H. Ochs,et al.  Use of intravenous gamma-globulin in antibody immunodeficiency: results of a multicenter controlled trial. , 1982, Clinical immunology and immunopathology.

[306]  K. Reid,et al.  The proteolytic activation systems of complement. , 1981, Annual review of biochemistry.

[307]  J. Finlayson,et al.  A urokinase-incubation method for predicting the stability of immune globulin. , 1978, Journal of biological standardization.

[308]  Y. Masuho,et al.  Development of an intravenous gamma-globulin with Fc activities. II. Reconversion of S-sulfonated human gamma-globulin into the original gamma-globulin. , 1977, Vox sanguinis.

[309]  H. Dickler.  Lymphocyte receptors for immunoglobulin. , 1976, Advances in immunology.

[310]  I. Katayama,et al.  Letter: Hairy Cells. , 1975, Lancet.

[311]  R. Stephens.  Letter: Splenectomy and lymphomas. , 1975, Lancet.

[312]  D. Danks,et al.  Letter: Anticonvulsants and congenital abnormalities. , 1974, Lancet.

[313]  B. Meyers,et al.  Current patterns of infection in multiple myeloma. , 1972, The American journal of medicine.

[314]  W. Stephan.  Beseitigung der Komplementfixierung von γ-Globulin durch chemische Modifizierung mit β-Propiolacton , 1969 .

[315]  T. Waldmann,et al.  Metabolism of immunoglobulins. , 1969, Progress in allergy.

[316]  Hansson Ub.  Aggregation of human immunoglobulin G upon freezing. , 1968 .

[317]  L. Hanson,et al.  Studies on the elimination of the complement inhibiting activity of human gamma-globulin using degradation with plasmin or gel filtration. , 1967, International archives of allergy and applied immunology.

[318]  L. J. Witts,et al.  Radioactive vitamin 12B after partial gastrectomy. , 1963 .

[319]  R. Sommerville.  Enteroviruses and diarrhoea in young persons. , 1958, Lancet.